Cargando…
Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation
BACKGROUND: Cancer-testis antigens (CTAs) are potential targets for cancer immunotherapy. Many CTAs are located on the X chromosome and are epigenetically regulated. Loss of X chromosome inactivation (XCI) is observed in breast and ovarian cancers and is thought to be related to the overexpression o...
Autores principales: | Kang, Jun, Lee, Hee Jin, Jun, Sun-Young, Park, Eun Su, Maeng, Lee-so |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567132/ https://www.ncbi.nlm.nih.gov/pubmed/26360551 http://dx.doi.org/10.1371/journal.pone.0137476 |
Ejemplares similares
-
Dysregulation of X Chromosome Inactivation in High Grade Ovarian Serous Adenocarcinoma
por: Kang, Jun, et al.
Publicado: (2015) -
Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2013) -
Rapid evolution of cancer/testis genes on the X chromosome
por: Stevenson, Brian J, et al.
Publicado: (2007) -
Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2018) -
miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer()()
por: Hovey, Adriann M., et al.
Publicado: (2015)